MX2022013829A - Methods of treating or preventing coronavirus infection. - Google Patents
Methods of treating or preventing coronavirus infection.Info
- Publication number
- MX2022013829A MX2022013829A MX2022013829A MX2022013829A MX2022013829A MX 2022013829 A MX2022013829 A MX 2022013829A MX 2022013829 A MX2022013829 A MX 2022013829A MX 2022013829 A MX2022013829 A MX 2022013829A MX 2022013829 A MX2022013829 A MX 2022013829A
- Authority
- MX
- Mexico
- Prior art keywords
- treating
- methods
- coronavirus infection
- preventing coronavirus
- preventing
- Prior art date
Links
- 208000001528 Coronaviridae Infections Diseases 0.000 title abstract 2
- 206010062016 Immunosuppression Diseases 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- BICRTLVBTLFLRD-PTWUADNWSA-N voclosporin Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O BICRTLVBTLFLRD-PTWUADNWSA-N 0.000 abstract 1
- 229960005289 voclosporin Drugs 0.000 abstract 1
- 108010057559 voclosporin Proteins 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Provided herein are methods of using voclosporin for treating or preventing coronavirus infection, particularly in subjects that require immunosuppression.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063022357P | 2020-05-08 | 2020-05-08 | |
| PCT/IB2021/053922 WO2021224890A1 (en) | 2020-05-07 | 2021-05-08 | Methods of treating or preventing coronavirus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022013829A true MX2022013829A (en) | 2023-04-03 |
Family
ID=85652803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022013829A MX2022013829A (en) | 2020-05-08 | 2021-05-08 | Methods of treating or preventing coronavirus infection. |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2023524802A (en) |
| CN (1) | CN115867305A (en) |
| MX (1) | MX2022013829A (en) |
-
2021
- 2021-05-08 CN CN202180046669.2A patent/CN115867305A/en active Pending
- 2021-05-08 MX MX2022013829A patent/MX2022013829A/en unknown
- 2021-05-08 JP JP2022567470A patent/JP2023524802A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023524802A (en) | 2023-06-13 |
| CN115867305A (en) | 2023-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020012028A (en) | Methods and compositions for treating cancer. | |
| MX2018007266A (en) | Combinations for the treatment of cancer. | |
| MX2023007212A (en) | Epinephrine spray formulations. | |
| MX2019010040A (en) | Compositions and methods for treatment of cancer. | |
| MX2022001004A (en) | Enzyme inhibitors. | |
| MX2021000847A (en) | Methods of treating cancer with pi3k inhibitor, gdc-0077. | |
| PH12021551036A1 (en) | Anti-liv1 immune cell cancer therapy | |
| EA202091881A1 (en) | COMPOUNDS FOR PAIN TREATMENT | |
| MX2022014034A (en) | Methods of treating covid-19 using bardoxolone methyl or analogs thereof. | |
| PH12019500758A1 (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
| WO2022053993A3 (en) | Treatments for sars-cov-2 infection (covid-19) | |
| MX2022013829A (en) | Methods of treating or preventing coronavirus infection. | |
| WO2023122260A3 (en) | Inhibitors of sars-cov-2 | |
| WO2021041324A3 (en) | Compositions and methods for the treatment of pathological pain and itch | |
| MX2021008716A (en) | Method for treating osteoarthritis pain by administering resiniferatoxin. | |
| MX2021009670A (en) | Cancer treatment. | |
| MX2021002818A (en) | Methods of treating cancer by inhibiting ubiquitin conjugating enzyme e2 k (ube2k). | |
| MX2023005171A (en) | Compositions and methods for treating solid cancer. | |
| EA202190226A1 (en) | METHODS FOR TREATMENT OF HFpEF USING DAPAGLIFLOSIN AND COMPOSITIONS CONTAINING IT | |
| MX2023004881A (en) | Pde9 inhibitors for treating cardiac failure. | |
| CR20230294A (en) | Method of preparing pralsetinib | |
| MX2022013883A (en) | Methylthioninium compounds for use in the treatment of covid-19. | |
| MX2022011027A (en) | Compositions and methods for treatment of cancer. | |
| MX2023006551A (en) | Cannabidiol for the treatment of refractory seizures. | |
| MX2022014131A (en) | Mono- and combination therapies. |